Altered Bone Geometry and Quality in Type 2 Diabetes Mellitus: Insights from Peripheral Quantitative Computed Tomography in an Indian Cohort Authors: Anuradha V. Khadilkar, Uma Divate, Vishwajit Satale, Satyajit S. Gill, Shrikanth Muralidharan Published: 2025 ABSTRACT ABSTRACTBackground:Type 2 Diabetes Mellitus (T2DM) is increasingly recognized as a risk factor for skeletal fragility, independent of bone mineral density (BMD).Objective:This prospective, cross-sectional case-control study investigated bone geometry using peripheral quantitative computed tomography (pQCT) in 100 patients with T2DM.Methodology:100 cases of Type 2 DM and healthy cohorts were compared for bone geometry at a tertiary care hospital.Results:Trabecular density was notably reduced in men, while both periosteal and endosteal circumferences were significantly diminished in both sexes, suggesting cortical thinning and compromised bone geometry.Conclusion:The findings suggest that pQCT provides valuable insights into microarchitectural deficits, explaining the increased fracture risk in T2DM. INTRODUCTION As per the International Diabetes Federation, by 2045, the number of Type 2 Diabetes Mellitus (T2DM) cases are expected to surpass 783 million.[1] The National Family Health Survey shows a 16.1% prevalence of T2DM among adults aged 15 years and older.[2] It is known to raise the risk associated with osteoporosis, make muscles weak, and eventually the patient is vulnerable to fractures.[3] Other factors such as obesity, architectural integrity and metabolic influences alter the health of bones, even so, more in DM cases.[4] Factors that are outcomes of DM complications such as poor vision, elevated fall risk among elderly, poor glycemic control and side effects of therapies exaggerate the existing conditions and hence it is strongly associated with impaired bone quality.[56] DXA is the gold standard for assessment of bone density, however, it cannot describe bone geometry or differentiate between cortical and trabecular bone like the peripheral quantitative computed tomography (pQCT) can.[7] Essential elements such as cortical porosity are highlighted through pQCT helping clinicians to make a better diagnosis.[8] There are very few studies in the Indian population that have discussed the application of pQCT in determining bone geometry of T2 DM cases in comparison with healthy cohorts. This study aims to highlight these differences. MATERIAL AND METHOD This prospective, cross-sectional study was conducted at Jehangir Hospital in Pune, India, after obtaining approval from the Institutional Ethics Committee. A total of 100 patients with T2DM, aged between 45 and 75 years, and with a disease duration of at least 5 years, were recruited alongside 100 age- and sex-matched healthy controls from individuals undergoing routine health check-ups. Data collection involved anthropometric measurements and bone geometry evaluated through pQCT and the key parameters analyzed include cortical thickness (CRT_THK_C2), trabecular density (B_TrbDen1), cortical density (B_CrtDen2), total density (B_TotDen2), periosteal circumference (PERI_C2), endosteal circumference (ENDO_C2), bone areas, section modulus (B_SSIPOL2), and muscle area. Group comparisons were conducted via student’s t-test for continuous data with statistical significance defined as P < 0.05. RESULTS Table 1 shows the distribution of cases across both groups in terms of height, BMI, and HbA1c status. Table 1The distribution of cases across both groups in terms of height, BMI, and HbA1c statusVariableCategoryNormal (n=100)T2DM (n=100)Age (years)<5020 (20%)15 (15%)50–5935 (35%)40 (40%)60–6930 (30%)30 (30%)≥7015 (15%)15 (15%)Height (cm)<16015 (15%)20 (20%)160–16940 (40%)45 (45%)170–17935 (35%)30 (30%)≥18010 (10%)5 (5%)BMI (kg/m²)<18.5 (Underweight)5 (5%)2 (2%)18.5–24.9 (Normal)50 (50%)30 (30%)25–29.9 (Overweight)35 (35%)40 (40%)≥30 (Obese)10 (10%)28 (28%) HbA1c <5.7 (Normal)85 (85%)5 (5%)5.7–6.4 (Prediabetes)15 (15%)20 (20%)≥6.5 (Diabetes)0 (0%)75 (75%) The distribution of cases across both groups in terms of height, BMI, and HbA1c status Compared to controls, T2DM patients had lower cortical thickness, cortical area, total bone area, and section modulus [Table 2]. Table 2Bone geometry parametersNormal (Mean±SD)T2DM (Mean±SD) P Cortical Thickness (mm)2.8±0.52.5±0.60.045Cortical Area (mm²)80.3±10.575.6±12.30.032Trabecular Area (mm²)150.7±20.4140.2±22.10.058Total Bone Area (mm²)230.5±25.6215.3±28.70.041Section Modulus (mm³)1500.2±200.31380.7±215.50.029 Bone geometry parameters The pQCT data show that T2DM subjects have consistently poorer bone quality than normal, with significantly lower trabecular density in men and markedly reduced periosteal and endosteal circumferences in both sexes [Table 3]. Table 3Distribution based on sex and pQCT variablespQCT Parameters (Median [Range])Normal Male (n=50)Normal Female (n=50)T2DM Male (n=50)T2DM Female (n=50)P (Male)P (Female)B_TrbDen1 (mg/cm³)165.6 [140–215]176.5 [148–206]135.7 [110–159]121.2 [103–132]0.0180.091B_CrtDen2 (mg/cm³)1156 [1137–1177]1143.5 [1135–1172]1109.4 [1066–1131]1057.4 [1018–1140]0.2070.29B_TotDen2 (mg/cm³)746.5 [661–799]765.8 [670–825]670.0 [569–725]664.9 [574–743]0.6790.813Muscle Area (mm²)3349 [3119–3653]3353.3 [3036–3642]2205.4 [2010–2419]2196.6 [1905–2499]0.130.95CRT_THK_C2 (mm)2.2 [2.1–2.5]2.3 [2.0–2.5]1.7 [1.4–1.9]1.7 [1.5–1.9]0.9320.794PERI_C2 (mm)43.4 [41.5–44.4]41.8 [39.8–43.6]37.2 [35.9–38.8]35.3 [32.6–37.0]0.0070.002ENDO_C2 (mm)28.4 [26.1–31.0]27.5 [24.4–30.5]26.7 [24.3–29.0]24.7 [22.4–26.2]0.0210.005B_SSIPOL2 (mm³)305.2 [275–338]296.3 [240–332]187.2 [164–217]168.9 [149–210]0.1520.394pQCT=peripheral quantitative computed tomography Distribution based on sex and pQCT variables pQCT=peripheral quantitative computed tomography DISCUSSION The present study demonstrates that subjects with T2DM exhibit significant alterations in bone density and geometry despite being age- and sex-matched to healthy controls. These findings corroborate evidence that bone fragility in T2DM is not adequately explained by bone mineral density (BMD) alone, but rather by qualitative changes in microarchitecture and geometry that compromise bone strength.[910] The reduction in PERI_C2 and ENDO_C2 reflects impaired periosteal expansion and increased endosteal resorption, both of which reduce cortical thickness reducing the section modulus and bending strength, predisposing to fractures.[1112] B_CrtDen2, B_TotDen2, muscle area, and CRT_THK_C2 were lower in T2DM, these differences are not statistically significant. This discrepancy likely reflects inter-individual variability related to glycemic control, disease duration, body composition, and comorbidities. Cortical parameters consistently show deterioration, underlining its selective vulnerability to diabetic damage.[1314] The mechanisms underlying these deficits are multifactorial. Chronic hyperglycemia leads to advanced glycation product–mediated collagen stiffening and reduced bone toughness,[15] while microvascular complications impair osteocyte viability and remodeling,[16] and diminished bone turnover accelerates microdamage accumulation.[17] Our findings suggest that both trabecular and cortical pathways are implicated in skeletal fragility in T2DM, weaken the bone resistance to bending and torsion, increasing the risk of hip and long bone fractures—sites where T2DM patients exhibit higher fracture rates. CONCLUSION The findings of the present study demonstrate that T2DM is associated with trabecular loss and significant cortical thinning, particularly evident in reduced periosteal and endosteal circumferences. These alterations compromise bone geometry and strength, helping to explain the elevated fracture risk in T2DM despite preserved BMD. Conflicts of interest There are no conflicts of interest.